Exact Sciences earnings were -$986.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EXAS earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$19.6M, up 1,553.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EXAS reported annual earnings of -$1.0B, with 404% growth.
On EXAS's earnings call on Invalid Date, Exact Sciences (NASDAQ: EXAS) reported Q3 2025 earnings per share (EPS) of -$0.10, up 52.38% year over year. Total EXAS earnings for the quarter were -$19.59 million. In the same quarter last year, Exact Sciences's earnings per share (EPS) was -$0.21.
As of the last Exact Sciences earnings report, Exact Sciences is currently losing money. Exact Sciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$986.58 million, a 360.94% increase year over year.
What was EXAS's earnings growth in the past year?
As of Exact Sciences's earnings date in Invalid Date, Exact Sciences's earnings has grown year over year. EXAS earnings in the past year totalled -$986.58 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.